Last reviewed · How we verify

NCT05973292

Endocrowns in Anterior Teeth: Effect of Cementation Protocols and Restorative Materials on the Clinical Performance of the Restorations

Completed Phase 2 Last updated 2 August 2023
What this trial tests

Phase 2 trial testing resin cement containing phosphate ester monomer 10-methacryloyloxydecyl dihydrogen phosphate in Endodontically Treated Teeth in 40 participants. Completed in 1 April 2022.

Timeline
1 April 2021
Primary endpoint
1 April 2022
1 April 2022

Quick facts

Lead sponsorKafrelsheikh University
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date1 April 2021
Primary completion1 April 2022
Estimated completion1 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Kafrelsheikh University

Who can join

Adults 18 to 60, any sex, with Endodontically Treated Teeth or Anterior Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Rehabilitation of anterior endodontically treated teeth with significant coronal damage has been problematic. Adopting endocrown design to treat teeth with this condition is still under investigation. To address this issue, the USPHS criteria were adopted to assess the anterior endocrown restorations manufactured using various ceramic materials and cemented with different protocols.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endodontically Treated Teeth

Currently open trials in the same condition.

Other Kafrelsheikh University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05973292.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing